← TrialMatch
HomeTrials

Host-Diet-Gut Interaction Post Vegan Diet in Pediatric Autoimmune Hepatitis.

Pediatric autoimmune liver diseases (AILDs), including autoimmune hepatitis (AIH) and overlap syndromes like sclerosing cholangitis, are among the most common chronic liver conditions in the pediatric population. Currently, the treatment for AIH often involves long-term use of immunosuppressive therapy, which carries r

Condition(s)Autoimmune Hepatitis
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryPediatric autoimmune liver diseases (AILDs), including autoimmune hepatitis (AIH) and overlap syndromes like sclerosing cholangitis, are among the most common chronic liver conditions in the pediatric population. Currently, the treatment for AIH often involves long-term use of immunosuppressive therapy, which carries risks of severe side effects both in the short and long term. Due to these potential adverse effects, there is a critical need to explore alternative therapies that can modulate autoimmunity and potentially reduce or eliminate the dependence on immunosuppressive drugs. Autoimmune diseases, including AIH, typically arise in genetically predisposed individuals after exposure to certain environmental factors, leading to a breakdown in self-tolerance.The gut microbiome plays a cru
Who can participateInclusion Criteria: 1. Cases diagnosed as Autoimmune hepatitis (AIH). 2. Controls are healthy subjects. Exclusion Criteria: 1. Recent (\< 6 weeks) exposure to oral or intravenous antibiotics, probiotics/prebiotics, proton pump inhibitors, or herbal medicines. 2. Any history of malignancy or any gastrointestinal tract surgery. 3. Recent (\< 2 weeks) gastrointestinal infection. 4. Any dietary allergies .
Ages0 Years to 18 Years
SexAll
Lead sponsorInstitute of Liver and Biliary Sciences, India
LocationsNew Delhi, National Capital Territory of Delhi, India
Start date2026-02-11
NCT IDNCT07118657
Official listinghttps://clinicaltrials.gov/study/NCT07118657

🔍 Search all trials →